Dexerials (4980) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The key point of this earnings report is that profitability declined amid virtually flat revenue, resulting in higher revenue but lower profit. Revenue was ¥873.0B (+0.2% year on year), Operating Income was ¥304.5B (△7.3%), and Net Income was ¥212.7B (△8.9%). The Operating Income margin remained high at 34.9%, but declined by approximately 2.8pt from the previous year, indicating a slight weakening in profitability while maintaining the revenue scale.

Factors Affecting Business Performance

【Revenue】Revenue was ¥873.0B, virtually flat at +0.2% year on year. Progress toward the full-year forecast of ¥1,140.0B (+3.3% year on year) was broadly at a standard level, and achievement of the full-year plan is predicated on revenue growth from Q4 onward.

【Profit and Loss】Operating Income declined to ¥304.5B (△7.3% year on year), while Net Income declined to ¥212.7B (△8.9%). The gross margin was 56.8% and the SG&A ratio was 20.8%; increases in cost of sales and SG&A expenses put pressure on Operating Income. Against Profit Before Tax of ¥305.6B, the Company recorded income taxes of ¥92.9B (effective tax rate: 30.4%), resulting in Net Income of ¥212.7B. The conclusion is higher revenue but lower profit.

Key Financial Indicators

【Profitability】The Operating Income margin of 34.9% and Net Income margin of 24.4% were both high, but declined from approximately 37.7% and 26.8%, respectively, in the previous year, indicating a slight weakening in profitability. ROE remained high at 20.9%, reflecting strong capital efficiency.【Cash Quality】Cash and cash equivalents were ¥146.5B, a significant decline from ¥349.8B in the previous year, warranting attention to changes in the funding level.【Investment Efficiency】Net assets were ¥1019.5B against total assets of ¥1555.5B, with asset efficiency supported by business profitability.【Financial Soundness】The Equity Ratio was 65.5%, improving from 63.2% in the previous year, indicating a substantial capital buffer. BPS was ¥608.64, up from ¥570.77 in the previous year.

Cash Flow Analysis

Although detailed disclosure of the cash flow statement is not available, an analysis of funding trends based on changes in the balance sheet indicates that cash and cash equivalents were ¥146.5B, a decrease of ¥203.3B from ¥349.8B in the previous year. Meanwhile, property, plant and equipment increased significantly from ¥682.6B year on year, suggesting that funding allocation toward capital investment progressed. Accounts receivable were ¥230.2B, up from ¥179.8B in the previous year, while inventories were also ¥106.5B, up from ¥87.4B, indicating that an accumulation of working capital may have contributed to the decline in cash. Interest-bearing debt totaled ¥168.5B on a current and non-current basis, down from ¥210.8B in the previous year, indicating a certain degree of cash outflow related to financing activities.

Quality of Earnings

The gap between Operating Income and Profit Before Tax was small. Profit Before Tax was ¥305.6B after financial income of ¥0.5B, financial expenses of ¥2.0B, other income of ¥3.1B, other expenses of ¥13.3B, and equity-method income of ¥2.6B. Equity-method investment income of ¥2.6B accounted for only approximately 1.2% of Net Income, with core earnings centered on Operating Income from the main business. Comprehensive income was ¥218.7B, slightly above Net Income of ¥212.7B, with other comprehensive income, including foreign currency translation adjustments of ¥5.2B, serving as an upward contributor. The decline in profit despite revenue growth at the operating level should be viewed not as a temporary factor, but as a change in the recurring earnings structure accompanied by changes in the gross margin and SG&A ratio.

Earnings Forecast and Guidance

The full-year forecast is Revenue of ¥1,140.0B (+3.3% year on year), Operating Income of ¥390.0B (△1.9%), and Net Income of ¥260.0B. Cumulative progress rates were 76.6% for Revenue, 78.1% for Operating Income, and 81.8% for Net Income, all exceeding the standard progress rate of 75%. The Operating Income margin required in Q4 is 32.0%, below the cumulative actual result of 34.9%; therefore, the hurdle for achieving the full-year plan is not excessively high from a margin perspective.

Shareholder Returns

The Q2 dividend was ¥29.00 per share, while the full-year company forecast calls for an annual dividend of ¥58.00, consisting of a year-end dividend equal to the interim dividend. The forecast Payout Ratio calculated from forecast Net Income of ¥260.0B, an annual dividend of ¥58.00, and the average number of shares outstanding during the period of 168,478,555 shares is approximately 37.6%, a level below the benchmark for dividend-only sustainability. Retained earnings of ¥754.3B and an Equity Ratio of 65.5% provide financial support for continued dividend payments.

Risk Factors

1. Declining profitability: While Revenue was virtually flat at +0.2% year on year, the Operating Income margin declined by approximately 2.8pt from the previous year to 34.9%. If changes in product mix, costs, and fixed-cost absorption continue, they could affect the sustainability of high profitability.

2. Increase in working capital: Accounts receivable increased to ¥230.2B (¥179.8B in the previous year), while inventories increased to ¥106.5B (¥87.4B in the previous year). Increases at a pace exceeding revenue growth warrant monitoring for their impact on capital efficiency and inventory valuation.

3. Goodwill level: Goodwill was ¥212.9B, accounting for 20.9% of net assets. If the profitability of acquired businesses declines, the sensitivity of future cash flows and other assumptions underlying impairment risk may increase.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company's profitability metrics significantly exceed the industry median, placing it among the highly profitable groups within the manufacturing industry.

Growth and Capital Efficiency

The Revenue growth rate is below the industry median, indicating that growth is relatively less impressive compared with the Company's high profitability.

※Source: Compiled by the Company

Key Points from the Earnings Report

1. The Operating Income margin of 34.9% and Net Income margin of 24.4% represent a highly profitable structure significantly above the industry median. However, margins have declined from the previous year, making it important to determine whether this decline is temporary or structural.

2. Progress toward the full-year forecast was above standard, at 78.1% for Operating Income and 81.8% for Net Income, indicating that the Company plan is within an achievable range when compared with cumulative actual results.

3. Accounts receivable and inventories are increasing at a pace exceeding revenue growth. Working capital efficiency will therefore be a key point to verify when assessing the conversion of profit into cash.

Theoretical Stock Price (Reference Value)

Sensitivity: ¥932–¥989 at ±1% for the cost of equity, and ¥951–¥974 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing gap relative to the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated values based solely on publicly disclosed data; these are not forecasts of market prices or recommendations for specific investment actions, and do not predict or guarantee future stock prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific issue. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional where necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Dexerials delivered resilient FY2026 Q3 cumulative revenue of ¥87.30bn, up 0.2% YoY, but profitability contracted as costs and below-operating-line expenses increased. Operating income was ¥30.45bn, down 7.3% YoY, and profit attributable to owners was ¥21.27bn, down 8.9% YoY. The operating margin declined 280bp YoY to 34.9% from 37.7%, although it remains exceptionally high for a manufacturing company. Gross margin declined modestly by 28bp to 56.8%, indicating that the principal earnings pressure was not solely attributable to production cost inflation. SG&A expenses increased 1.2% YoY to ¥18.14bn while revenue was broadly flat, raising the SG&A-to-sales ratio by 22bp to 20.8%. Profit before tax decreased by a smaller 5.9% to ¥30.56bn, supported by sharply lower finance costs and higher equity-method investment income. However, other income fell to ¥3.08bn from ¥19.25bn in the prior-year period, while other expenses rose to ¥13.28bn from ¥9.42bn. The effective tax rate increased to 30.4% from approximately 28.1% in the prior period, amplifying the decline from pre-tax profit to net income. Net margin consequently fell 244bp YoY to 24.4%, but remains at an excellent absolute level. Annualized ROE was 27.8%, supported by strong margins and efficient use of a conservatively capitalized balance sheet. Annualized ROA, calculated using annualized Q3 net income and average current/prior-period assets, was approximately 18.5%, also evidencing high capital productivity. The balance sheet strengthened in equity terms, with the equity ratio rising to 65.5% from 63.2%. At the same time, receivables rose 28.0% YoY and reported DSO reached 72 days, while inventory days were 77 days; this working-capital build warrants close attention amid flat sales. FY2026 full-year guidance implies Q4 revenue of ¥26.70bn, operating income of ¥8.55bn, and net income of ¥4.73bn. Cumulative progress is 76.6% for revenue, 78.1% for operating income, and 81.8% for net income, modestly ahead of the standard 75% Q3 run-rate and consistent with achieving guidance despite a softer Q4 implied profit profile. Overall, the result preserves the company’s high-return profile, but the investment debate is likely to focus on margin normalization, working-capital conversion, and the return on the substantially expanded production asset base.

Profitability Analysis

The reported annualized 27.8% ROE decomposes into a 24.4% net profit margin, 0.748x annualized asset turnover, and 1.53x financial leverage. The dominant driver of the high ROE is therefore the very strong profit margin rather than aggressive balance-sheet leverage. Financial leverage is moderate and consistent with the 65.5% equity ratio, so returns appear principally operating-led. Operating margin fell to 34.9% from 37.7%, a 280bp contraction and the most material adverse movement in the earnings structure. Gross margin slipped only 28bp to 56.8%, whereas SG&A grew 1.2% against 0.2% revenue growth; this points to negative operating leverage below gross profit. Other income declined by ¥16.17bn YoY and other expenses increased by ¥3.86bn, although these movements were partly offset by a ¥0.49bn reduction in finance costs and a ¥1.40bn increase in equity-method income. The tax burden was 0.696, slightly below the 0.70 normal benchmark, reflecting the 30.4% effective tax rate. The interest burden was 1.004 because pre-tax income marginally exceeded EBIT, demonstrating that finance costs are not a material constraint on earnings. The 34.9% EBIT margin and 24.4% net margin remain well above the stated excellent thresholds, but restoring margin momentum requires revenue growth to again exceed the pace of operating expenses.

Growth Assessment

Revenue was effectively flat YoY at ¥87.30bn, indicating limited top-line momentum through Q3. Operating income and net income fell faster than sales, confirming that the current earnings pressure is principally a profitability issue rather than a volume-led revenue contraction. Gross profit declined 0.4% YoY to ¥49.61bn, while SG&A increased to ¥18.14bn, reducing operating income by ¥2.40bn. The decline in other income and increase in other expenses further reduced the contribution from non-core items compared with the prior-year period. Equity-method investment income increased to ¥2.58bn from ¥1.18bn, providing a modest offset but representing less than 1% of pre-tax profit. Full-year guidance calls for revenue growth of 3.3% to ¥114.00bn, operating income of ¥39.00bn, down 1.9%, and net income of ¥26.00bn, down 6.3%. The guidance therefore anticipates a return to top-line growth without a full recovery in profit growth. Q3 progress versus guidance is 76.6% for revenue and 78.1% for operating income, both close to the standard 75% pace. Net-income progress of 81.8% is 6.8 percentage points ahead of the standard pace, but not sufficiently outside the normal range to suggest a material guidance variance. The implied Q4 operating margin is approximately 32.0%, below the Q3 cumulative 34.9% margin, making the exit-rate profitability assumption a key near-term monitor.

Financial Health

Financial health remains sound, with total equity of ¥101.95bn and an equity ratio of 65.5%, up 230bp YoY. Total liabilities were ¥53.59bn, equivalent to 0.53x equity on the reported debt-to-equity measure, well below the 2.0x aggressive-financing warning level. Interest-bearing debt totaled ¥16.85bn, comprising ¥3.59bn current and ¥13.26bn non-current, against ¥14.65bn of cash and cash equivalents. The current ratio was approximately 1.38x, based on current assets of ¥49.30bn and calculated current liabilities of ¥35.75bn; it is below the 1.5x healthy benchmark but safely above 1.0x. The quick ratio was approximately 1.05x, supported by cash and receivables, indicating that short-term liabilities are broadly covered by liquid assets. Short-term interest-bearing debt represents only about 10% of calculated current liabilities, limiting maturity-mismatch risk. PPE increased by ¥18.56bn, or 37.3% YoY, to ¥68.26bn and now represents 43.9% of total assets, demonstrating a more capital-intensive asset base. Receivables increased by ¥5.04bn, or 28.0% YoY, to ¥23.02bn despite flat revenue, and inventories increased by ¥1.81bn to ¥10.66bn. Goodwill remained ¥21.29bn, equal to 20.9% of equity and 13.7% of assets, which is within the healthy goodwill-to-equity benchmark. Intangible assets of ¥7.44bn represent 4.8% of total assets, implying no excessive intangible-asset concentration. Treasury stock expanded by ¥4.93bn to negative ¥9.66bn, increasing the contra-equity balance to 6.2% of total assets; the capital-allocation effect should be assessed alongside future shareholder-return actions.

Notable B/S Changes

Property, plant and equipment: +¥18.56bn (+37.3%) to ¥68.26bn - substantial capacity or production-asset investment increased capital intensity to 43.9% of total assets; utilization and returns are key. Accounts receivable: +¥5.04bn (+28.0%) to ¥23.02bn - increase materially exceeded flat revenue growth and is consistent with the elevated 72-day DSO; collection performance requires monitoring. Treasury stock: -¥4.93bn (+104.4% in the negative balance) to -¥9.66bn - larger contra-equity balance reflects increased treasury-share holdings and is relevant to capital-allocation analysis. Retained earnings: +¥10.98bn (+17.0%) to ¥75.43bn - continued earnings retention reinforces equity capacity and supports investment and dividend flexibility.

Cash Flow Quality

Cash and cash equivalents were ¥14.65bn at Q3, down ¥20.33bn YoY from ¥34.98bn. The decline occurred alongside a ¥18.56bn increase in PPE, a ¥5.04bn increase in receivables, and a ¥1.81bn increase in inventories, indicating a materially greater capital and working-capital funding requirement than in the prior-year period. Receivable days of 72 exceed the 60-day warning threshold. Inventory days of 77 also exceed the 60-day warning threshold, although they remain below the 90-day level generally associated with a more severe excess-inventory warning. The 72-day DSO is the more acute concern because receivables grew substantially faster than revenue, which was flat YoY. Higher inventory and receivables can be consistent with capacity build-out and customer shipment timing, but they increase the cash conversion burden if not reversed through Q4. Accounts payable increased by ¥2.51bn to ¥14.79bn, partly funding the increase in operating working capital. The operating cash flow, free cash flow, and OCF-to-net-income conversion cannot be derived from the supplied figures; therefore, the cash earnings-conversion assessment should center on whether the receivables and inventory build reverses as revenue develops.

Dividend Sustainability

The Q2 dividend was ¥29.00 per share. This represents a 24.1% payout against cumulative Q3 EPS of ¥126.23, using the disclosed calculation. Full-year guidance indicates DPS of ¥58.00 and basic EPS of ¥153.69, implying a forecast dividend payout ratio of approximately 37.7%. This remains comfortably below the 60% sustainability benchmark and leaves meaningful retained capital for investment and balance-sheet resilience. Retained earnings increased by ¥10.98bn YoY to ¥75.43bn, supporting dividend capacity. The company’s high forecast profitability and 65.5% equity ratio also provide a substantial buffer for ordinary dividends. The increase in treasury stock is relevant to shareholder returns, but a total return ratio cannot be calculated from the supplied figures. Dividend sustainability will depend on maintaining earnings conversion as receivables, inventories, and PPE investment absorb cash.

Risk Assessment

Business risks include Electronics-materials demand cyclicality: FY2026 guidance assumes 3.3% revenue growth after Q3 revenue was nearly flat YoY, leaving earnings sensitive to the timing and strength of customer demand recovery., Margin risk: operating margin contracted 280bp YoY to 34.9%, with SG&A rising faster than revenue; further weak sales absorption could extend negative operating leverage., Manufacturing working-capital risk: DSO of 72 days and inventory days of 77 both breach the supplied 60-day warning threshold. Receivables increased 28.0% YoY despite flat sales, raising collection and shipment-timing risk., Production-investment execution risk: PPE expanded 37.3% YoY to ¥68.26bn. The enlarged asset base requires sustained utilization and returns to protect capital efficiency..

Financial risks include Liquidity is adequate but less abundant than a year ago: cash declined ¥20.33bn YoY and the current ratio was approximately 1.38x, below the 1.5x healthy benchmark., Capital allocation risk: treasury stock increased by ¥4.93bn YoY, while cash resources have declined and production assets have expanded., Goodwill-related valuation risk is contained rather than elevated: goodwill is 20.9% of equity, below the 30% healthy benchmark, but continued value retention remains relevant..

Key concerns include Highest priority: conversion of the large receivables increase into cash and normalization of the 72-day DSO., High priority: whether implied Q4 operating margin of approximately 32.0% signals temporary seasonality or a more persistent margin reset., Medium priority: utilization and return generation from the ¥18.56bn YoY increase in PPE., Medium priority: execution against full-year guidance, particularly the requirement for Q4 revenue of ¥26.70bn..

Investment Implications

Key takeaways include The company retains an elite earnings profile, with a 34.9% operating margin, 24.4% net margin, and annualized ROE of 27.8%., Revenue stability did not prevent profit contraction: operating income fell 7.3% and net income fell 8.9% YoY., The earnings shortfall reflects SG&A deleverage, lower other income, higher other expenses, and a higher effective tax rate more than a major deterioration in gross margin., The balance sheet is conservatively capitalized, with a 65.5% equity ratio and reported D/E of 0.53x., Working-capital efficiency is the principal near-term financial-quality issue, given 72 DSO days and 77 inventory days., FY guidance remains achievable on cumulative progress, but it embeds an implied Q4 operating-margin step-down..

Metrics to watch include Revenue growth versus the FY2026 ¥114.00bn forecast, Operating margin versus the FY2026 guidance-implied level, SG&A growth relative to revenue growth, Receivable days and the collection of the ¥23.02bn receivables balance, Inventory days and inventory movement relative to revenue, Cash balance relative to PPE investment and shareholder-return activity, PPE utilization and capital productivity following the 37.3% YoY PPE increase, Effective tax rate relative to the Q3 30.4% level.

Regarding relative positioning, Dexerials is positioned as a high-margin, high-return electronics-materials manufacturer with a notably strong equity base and moderate leverage. Its current relative strength is profitability rather than growth: the 34.9% operating margin and 27.8% annualized ROE remain excellent, while flat revenue growth, margin compression, and elevated working-capital days are the principal offsets.